Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

Olainfarm Jumps to Record as Drugmaker Profit Soars: Riga Mover

AS Olainfarm, a Latvian drugmaker with sales in 30 countries, extended record gains after its third-quarter profit surged 49 percent from a year earlier.

The shares rose as much as 5.5 percent today in Riga and closed up 2.9 percent at 3.53 lats, the highest since trading began in 1998. Volume of 9,947 shares was the equivalent of 212 percent of the three-month daily average, according to data complied by Bloomberg.

Olainfarm has climbed 5.1 percent since it reported on Nov. 30 that net income increased to 2.7 million lats ($5 million) in the third quarter. The company said new purchasing policies helped it boost profitability.

Swedbank raised its price estimate for Olainfarm to 4 lats from 3.7 lats on Dec. 5 and kept its strong buy recommendation for the stock.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.